Effect of nonsteroidal anti-inflammatory drugs on osteogenesis and spinal fusion.
Reuben
S S
SS
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003576:Electron Transport Complex IV / Q000378:metabolism; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D007783:Lactones / Q000009:adverse effects / Q000627:therapeutic use; D008565:Membrane Proteins; D010012:Osteogenesis / Q000187:drug effects*; D010149:Postoperative Pain / Q000188:drug therapy; D011184:Postoperative Period; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D012189:Retrospective Studies; D013123:Spinal Fusion; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D007783:Lactones; D008565:Membrane Proteins; D013450:Sulfones; C116926:rofecoxib; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D003576:Electron Transport Complex IV